MASLD / Fatty Liver Specialist in India — Advanced Metabolic Liver Care
Most people still think fatty liver is “mild.”
That ignorance is exactly why India is heading toward a liver disease explosion.
MASLD (Metabolic dysfunction–Associated Steatotic Liver Disease) is not just fat in the liver. It is a systemic metabolic disease linked to:
obesity
diabetes
insulin resistance
PCOS
hypertension
sleep apnea
cardiovascular risk
cirrhosis
liver cancer
And here is the uncomfortable truth:
A large number of patients with “normal liver tests” already have progressive fibrosis.
That is why generic diet advice and random supplements are failing patients.
Dr. Chetan Kalal — MASLD / Fatty Liver Specialist, India
Dr Chetan Kalal Official Website
Advanced expertise in:
MASLD / NAFLD / NASH
Obesity-related liver disease
Metabolic cirrhosis
Lean fatty liver
Advanced fibrosis assessment
FibroScan interpretation
Elevated SGPT/SGOT evaluation
Diabetes-associated liver disease
Liver risk stratification
Weight-loss therapy integration
Pre-transplant metabolic optimization
Serving patients across:
Mumbai
Delhi
Bengaluru
Hyderabad
Chennai
Pune
Global virtual consults for patients in the United States, United Kingdom, Canada, Australia, Dubai and Asia-Pacific.
What Makes Modern MASLD Care Different
Trash-level fatty liver care looks like this:
“Lose weight.”
“Take vitamin E.”
“Come after 6 months.”
That is lazy medicine.
Real MASLD management requires:
fibrosis staging
metabolic phenotype analysis
cardiovascular risk assessment
body composition evaluation
sarcopenia detection
insulin resistance targeting
GLP-1/GIP therapy integration
nutrition precision
long-term liver outcome planning
The future of hepatology belongs to metabolic liver medicine.
Doctors who still treat fatty liver like a harmless ultrasound finding are already outdated.
MASLD specialist India
Fatty liver specialist Mumbai
NASH expert India
Best hepatologist for fatty liver
FibroScan expert Mumbai
Advanced metabolic liver clinic India
Obesity and fatty liver specialist
Liver fibrosis assessment expert
Cirrhosis prevention specialist
Metabolic liver disease second opinion
“Not every fatty liver patient develops cirrhosis.
But the ones who do are usually identified too late.”
“Fatty liver is no longer a cosmetic diagnosis. It is metabolic liver disease.”
“The goal is not just weight loss — it is fibrosis reversal and long-term liver protection.”
“Advanced MASLD care requires hepatology, metabolic medicine, and precision risk assessment working together.”
Appointment & Virtual Consults
Book MASLD / Fatty Liver Consultation
Consultation support for:
FibroScan review
Fatty liver staging
Elevated liver enzymes
NASH/MASH treatment planning
Obesity-related liver disease
GLP-1 therapy guidance
Cirrhosis risk evaluation
International second opinions
Advanced metabolic liver management
